| Dec'18 | Dec'17 | Dec'16 | ||||
|---|---|---|---|---|---|---|
Net sales | ||||||
127,580 | 123,340 | - | ||||
Cost of goods sold | ||||||
112,348 | 104,698 | - | ||||
Net sales | ||||||
- | - | 103,803 | ||||
Cost of goods sold | ||||||
- | - | 87,417 | ||||
Gross profit | ||||||
15,232 | 18,642 | 16,386 | ||||
Research and development costs | ||||||
1,896 | 2,070 | 1,999 | ||||
Selling, general and administrative expense | ||||||
12,252 | 11,450 | 8,377 | ||||
Loss on impairment of goodwill | ||||||
30,579 | - | - | ||||
Operating income | ||||||
-29,495 | 5,122 | 6,010 | ||||
Other income (expense) | ||||||
Interest expense | ||||||
1,946 | 3,034 | 4,963 | ||||
Loss on debt extinguishment | ||||||
- | -989 | -2,196 | ||||
Loss on sale of assets | ||||||
- | - | -24 | ||||
Other income | ||||||
9 | 2 | - | ||||
Total other expense | ||||||
-1,937 | -4,021 | -7,183 | ||||
(Loss) Income before income taxes | ||||||
-31,432 | 1,101 | -1,173 | ||||
Income tax expense (benefit) | ||||||
698 | -608 | - | ||||
Net (loss) income | ||||||
-32,130 | 1,709 | -1,173 | ||||
Earnings per share: | ||||||
Basic net (loss) income per share of common stock | ||||||
-3.27 | 0.19 | -0.15 | ||||
Diluted net (loss) income per share of common stock | ||||||
-3.27 | 0.19 | -0.15 | ||||
Weighted average common shares outstanding: | ||||||
Basic weighted average common shares outstanding | ||||||
9,828 | 9,125 | 8,000 | ||||
Diluted weighted average common shares outstanding | ||||||
9,828 | 9,125 | 8,000 | ||||
Pro forma tax expense | ||||||
- | - | -422 | ||||
Pro forma net income | ||||||
- | - | -751 | ||||
Basic net income per share | ||||||
- | - | -0.09 | ||||
Diluted net income per share | ||||||
- | - | -0.09 | ||||